MAGGIE JONES: Open Payments
NPI 1144268210 · MADISON HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 13 payments from 12 companies in 2025. Trend: 2023 $1,426 · 2024 $1,861 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $258 |
| Teva Pharmaceuticals USA, Inc. | 1 | $132 |
| SOBI, INC | 1 | $132 |
| GENZYME CORPORATION | 1 | $126 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
Products named: Kerendia, UZEDY, Gamifant, CERDELGA, PYRUKYND, REXULTI, EPIDIOLEX, Adempas.
Industry payments across MI — which companies pay providers there.
